BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 29, Issue 6
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (14827)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.
Item 
Count 
PDF683
WORD121
HTML11353
Figures (1-4)580
Tables (1-3)632
 Sum=13369
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse303
Download789
 Sum=1092
Feb 14, 2023 (publication date) through Jan 12, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Mandlik DS, Mandlik SK, Choudhary HB. Immunotherapy for hepatocellular carcinoma: Current status and future perspectives. World J Gastroenterol 2023; 29(6): 1054-1075 [PMID: 36844141 DOI: 10.3748/wjg.v29.i6.1054]
URL: https://www.wjgnet.com/1007-9327/full/v29/i6/1054.htm
Number Citing Articles
1
Yanqing Huang, Xiaoying Yang, Mengda Wei, Xi Yang, Zhenmin Yuan, Junjie Huang, Junren Wei, Lei Tian. FUT11 expression in gastric cancer: its prognostic significance and role in immune regulation. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01120-y
2
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023. World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
3
Xingxing He, Jianping Liu, Yulian Zhang, Bushan Xie. Transcriptomic profiling of autophagy and apoptosis pathways in liver cancer cells treated with a new tyrosine kinase inhibitor PD161570. Molecular Medicine Reports 2025; 32(1): 1 doi: 10.3892/mmr.2025.13540
4
Zechang Zhang, Yuanyuan Yang, Yujia Zhang, Jing Wang, Huaifang Cai, Lei Yang, Wenxuan Liu. The construction and analysis of a prognostic model based on CD8 + T cell immune-related genes in hepatocellular carcinoma . Nucleosides, Nucleotides & Nucleic Acids 2025; : 1 doi: 10.1080/15257770.2025.2531134
5
Shuai Wang, PeiHan Wu, Nan Xu, ZhaoFeng Xiao, YanPeng Liu, WeiXiang Bian, LiJun Meng, RuiCen Guo, YingXi Xu, HongDa Ding. MSR1+ macrophages passivate antitumor immunity by inducing ITM2A+ CD4T exhaustion differentiation. Hepatology 2025;  doi: 10.1097/HEP.0000000000001578
6
Yuri I. Buziashvili, Elmira U. Asymbekova, Elvina F. Tugeeva, Elena V. Artamonova, Firdavsdzhon R. Akildzhonov. Cardiotoxicity of checkpoint inhibitors: focus on immune side effects. Heart, Vessels and Transplantation 2024; 0(Ahead of Print) doi: 10.24969/hvt.2024.480
7
Shamar Young, Jack Hannallah, Dan Goldberg, Tina Sanghvi, Junaid Arshad, Aaron Scott, Gregory Woodhead. Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape. International Journal of Molecular Sciences 2023; 24(14): 11434 doi: 10.3390/ijms241411434
8
Nasim Rahimi-Farsi, Taha Shahbazi, Abozar Ghorbani, Negar Mottaghi-Dastjerdi, Fateme Yazdani, Parvin Mohseni, Pietro Hiram Guzzi, Gita Esmail nia, Behzad Shahbazi, Khadijeh Ahmadi. Network-based analysis of candidate oncogenes and pathways in hepatocellular carcinoma. Biochemistry and Biophysics Reports 2025; 43: 102086 doi: 10.1016/j.bbrep.2025.102086
9
Alexandra M. Vázquez Salgado, Chunmiao Cai, Markcus Lee, Dingzi Yin, Marie-Lise Chrystostome, Adrienne F. Gefre, Shirui He, Julia E. Kieckhaefer, Kirk J. Wangensteen. In Vivo CRISPR Activation Screening Reveals Chromosome 1q Genes VPS72, GBA1, and MRPL9 Drive Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology 2025; 19(5): 101460 doi: 10.1016/j.jcmgh.2025.101460
10
Zeynep Akbulut, Başak Aru, Furkan Aydın, Gülderen Yanıkkaya Demirel. Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1379622
11
Tennyson Prakash Rayginia, Chenicheri Kizhakkeveettil Keerthana, Sadiq Chembothumparambil Shifana, Maria Joy Pellissery, Ajmani Abhishek, Ruby John Anto. Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma. Current Medicinal Chemistry 2024; 31(32): 5199 doi: 10.2174/0109298673275501231213063902
12
Ziqiang Li, Qingyong Hong, Zhizhan Ni, Zhidong Guo, Qimeng Shi, Xianqing Wang, Qi Huang, Kun Li, Bujun Ge. A Novel Nomogram for Prediction of Survival in Patients with Small Isolated Hepatocellular Carcinoma: A Population-Based and Externally Validated Study. Journal of Investigative Surgery 2025; 38(1) doi: 10.1080/08941939.2025.2536627
13
Yifei Qin, Fei Huo, Zhuan Feng, Jialu Hou, Yaxin Ding, Quancheng Wang, Yu Gui, Ziwei Yang, Jiali Yang, Gang Zhou, Ling Li, Jianli Jiang, Lingmin Kong, Shijie Wang, Gang Nan, Dingqiao Xu, Xiaohang Xie, Lijuan Wang, Qian He, Ruibin Yang, Peng Lin, Huijie Bian, Zhi-Nan Chen, Jiao Wu. CD36 promotes iron accumulation and dysfunction in CD8+ T cells via the p38-CEBPB-TfR1 axis in early-stage hepatocellular carcinoma. Clinical and Molecular Hepatology 2025; 31(3): 960 doi: 10.3350/cmh.2024.0948
14
Chaowen Zheng, Peng Dai, Hui You, Zhaokun Xian, Wenyun Su, Shixiong Wu, Dong Xing, Cuimin Sun. A compact microfluidic laser-induced fluorescence immunoassay system using avalanche photodiode for rapid detection of alpha-fetoprotein. Analytical Sciences 2024; 40(7): 1239 doi: 10.1007/s44211-024-00553-3
15
Erfan Taherifard, Krystal Tran, Ali Saeed, Jehad Amer Yasin, Anwaar Saeed. Biomarkers for Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma: A Comprehensive Review. Diagnostics 2024; 14(18): 2054 doi: 10.3390/diagnostics14182054
16
Magdolna Casian, Ioana Manea, Oana Hosu-Stancioiu, María Jesús Lobo Castañón, Noemí de-los-Santos-Álvarez, Cecilia Cristea. Targeting hepatocellular carcinoma with aptamers: from biomarker detection to therapeutic applications. TrAC Trends in Analytical Chemistry 2025; 191: 118346 doi: 10.1016/j.trac.2025.118346
17
Atieh Pourbagheri‐Sigaroodi, Majid Momeny, Nima Rezaei, Fatemeh Fallah, Davood Bashash. Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies. Cell Biochemistry and Function 2024; 42(5) doi: 10.1002/cbf.4098
18
Chia-Sheng Chu, Li-Ling Wu. Macrophages - Molecular Pathways and Immunometabolic Processes. 2024;  doi: 10.5772/intechopen.1005161
19
Silvia Pedretti, Francesca Palermo, Miriana Braghin, Gabriele Imperato, Pasquale Tomaiuolo, Meral Celikag, Marta Boccazzi, Veronica Vallelonga, Lorenzo Da Dalt, Giuseppe Danilo Norata, Giorgia Marisi, Ilario Giovanni Rapposelli, Andrea Casadei-Gardini, Serena Ghisletti, Maurizio Crestani, Emma De Fabiani, Nico Mitro. D-lactate and glycerol as potential biomarkers of sorafenib activity in hepatocellular carcinoma. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02282-z
20
Faris Alrumaihi, Reem A. Alromaihi, Vikalp Kumar, Shehwaz Anwar. Cancer Vaccines: Molecular Mechanisms, Clinical Progress, and Combination Immunotherapies with a Focus on Hepatocellular Carcinoma. Current Issues in Molecular Biology 2025; 47(12): 1056 doi: 10.3390/cimb47121056
21
Yanxi Luo, Zhigao Hu, Guoxiu Du, Wanpeng Xin, Minglong Wang. Novel immune checkpoint inhibitor FilC/PD-1 recombinant vaccinia virus inhibits hepatocellular carcinoma. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1622209
22
Vincent Chin-Hung Chen, Shao-Lan Huang, Jing-Yu Huang, Tsai-Ching Hsu, Bor-Show Tzang, Roger S. McIntyre. Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis. International Journal of Molecular Sciences 2023; 24(16): 12630 doi: 10.3390/ijms241612630
23
Litao Huang, Deying Kang, Chongyang Zhao, Xueting Liu. Correlation between surrogate endpoints and overall survival in unresectable hepatocellular carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-54945-6
24
Shayan Sadrinasab, Sadaf Saket, Nadia Pourmohammadi, Fatemeh Khosravi, Masoud Saadat Fakhr. Modern therapeutic approaches for hepatic tumors: progress, limitations, and future directions. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02773-z
25
Natalia Kluz, Hanna Grabowska, Paulina Chmiel, Kornelia Rynkiewicz, Alicja Skrobucha, Ewa Wysokińska, Łukasz Szymański, Piotr Tomasz Wysocki, Aleksandra Semeniuk-Wojtaś, Leszek Kraj. Platelets in Hepatocellular Carcinoma—From Pathogenesis to Targeted Therapy. Cancers 2025; 17(14): 2391 doi: 10.3390/cancers17142391
26
Emanuele Federico Kauffmann, Michael Ginesini, Allegra Ripolli, Paolo De Simone. THE CHANGING LANDSCAPE OF TRANSPLANT ONCOLOGY: OPPORTUNITIES AND CHALLENGES. European Journal of Transplantation 2025; 3(1): 3 doi: 10.57603/EJT-1561
27
Muhammad Zafar Saleem, Ghulam Zahra Jahangir, Ammara Saleem, Asma Zulfiqar, Khalid Ali Khan, Sezai Ercisli, Baber Ali, Muhammad Hamzah Saleem, Aroona Saleem. Production Technologies for Recombinant Antibodies: Insights into Eukaryotic, Prokaryotic, and Transgenic Expression Systems. Biochemical Genetics 2025; 63(5): 3928 doi: 10.1007/s10528-024-10911-5
28
Shriraam Karunakaran, Mohan Krishna Ghanta, Anusha Lakshmi Cheetiyar, LVKS Bhaskar, Ganji Purnachandra Nagaraju. Integrated therapies for targeting the microenvironment of hepatocellular carcinoma. Drug Discovery Today 2026; 31(1): 104556 doi: 10.1016/j.drudis.2025.104556
29
Tasneem Abaza, Mostafa K. Abd El-Aziz, Kerolos Ashraf Daniel, Paraskevi Karousi, Maria Papatsirou, Sherif Ashraf Fahmy, Nadia M. Hamdy, Christos K. Kontos, Rana A. Youness. Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy. International Journal of Molecular Sciences 2023; 24(22): 16484 doi: 10.3390/ijms242216484
30
Maen Abdelrahim, Abdullah Esmail, Aiwu Ruth He, Moh’d Khushman, Yaser Rayyan. Advances in Immunotherapy for Transplant Oncology. Cancers 2024; 16(13): 2369 doi: 10.3390/cancers16132369
31
Mythileeswari Lakshmikanthan, Sakthivel Muthu, John T. D. Caleb, Yuvaraj Maria Francis, Indra Neel Pulidindi. Liver Cancer: Artificial Intelligence (AI)-Based Integrated Therapeutic Approaches. Bioengineering 2025; 12(8): 837 doi: 10.3390/bioengineering12080837
32
Soyul Ahn, Seung Eun Baek, Yeuni Yu, Eun Sun Kim, Kyungjae Myung, Yun Hak Kim, Chang-Kyu Oh. The role of AP2M1 in oncofetal characteristics: integrative in silico, in vitro, and in vivo analyses using zebrafish models. European Journal of Medical Research 2025; 31(1) doi: 10.1186/s40001-025-03583-3
33
Diguang Wen, Shuling Wang, Jiajian Yu, Ting Yu, Zuojin Liu, Yue Li. Analysis of clinical significance and molecular characteristics of methionine metabolism and macrophage-related patterns in hepatocellular carcinoma based on machine learning. Cancer Biomarkers 2024; 39(1): 37 doi: 10.3233/CBM-220421
34
Shamar Young, Jack Hannallah, Dan Goldberg, Mohammad Khreiss, Rachna Shroff, Junaid Arshad, Aaron Scott, Gregory Woodhead. Liver-Directed Therapy Combined with Systemic Therapy: Current Status and Future Directions. Seminars in Interventional Radiology 2023; 40(06): 515 doi: 10.1055/s-0043-1777711
35
Nguyen Pham, Jihane N. Benhammou. Statins in Chronic Liver Disease: Review of the Literature and Future Role. Seminars in Liver Disease 2024; 44(02): 191 doi: 10.1055/a-2319-0694
36
Zhongxue Guo, Peining Yu, Liu Yu, Mengzhen Huang, Zhiwei Wu, Aime Gael Yaya Traore, Zhen Sun, Ziyou Bai, Wei Wu, Tongzheng Liu, Qiang Li, Feng Wang. Exon 13 skipping mediated by HNRNPL facilitates truncated SLK-induced metastasis in hepatocellular carcinoma. Biochemical Pharmacology 2025; 242: 117390 doi: 10.1016/j.bcp.2025.117390
37
Ju. I. Buziashvili, E. U. Asymbekova, E. F. Tugeeva, E. V. Artamonova, F. R. Akildzhonov. Cardiotoxicity of checkpoint inhibitors: focus on immune side effects. Medical alphabet 2024; (7): 26 doi: 10.33667/2078-5631-2024-7-26-33
38
Yajie Pan, Ruyue Chen, Xueyan Lv, Yuehang Wang, Hongyu Zhang. Targeted delivery of IFN-α-anti-GPC3 fusion protein via mRNA-LNP platform elicits potent anti-tumor immunity in hepatocellular carcinoma. Drug Delivery and Translational Research 2025;  doi: 10.1007/s13346-025-01911-y
39
Yacob Saleh, Taher Abu Hejleh, Maen Abdelrahim, Ali Shamseddine, Laudy Chehade, Tala Alawabdeh, Issa Mohamad, Mohammad Sammour, Rim Turfa. Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation. Cancers 2024; 16(11): 2081 doi: 10.3390/cancers16112081
40
Yi Jiang, Ke Su, Han Li, Chenjie Wang, Zhenying Wu, Jiali Chen, Zhiyao Zhang, Kun He, Yunwei Han. Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study. Investigational New Drugs 2024;  doi: 10.1007/s10637-024-01468-6
41
Rui Zhang, Wei Peng, Yao Wang, Yunping Jiang, Junli Wang, Siying Zhang, Zhi Li, Yushu Shi, Feng Chen, Zhan Feng, Wenbo Xiao. MRI radiomics model for predicting tumor immune microenvironment types and efficacy of anti-PD-1/PD-L1 therapy in hepatocellular carcinoma. BMC Medical Imaging 2025; 25(1) doi: 10.1186/s12880-025-01751-9
42
Qingteng Zeng, Renjie Zhang, Xuan Zheng, Xiaobing Li, Qinghua He, Ruikun Zhang, Shenfeng Wu, Boqian Chen. Effectiveness and Safety of Combining Transarterial Chemoembolization with Tyrosine Kinase and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Meta-Analysis. Oncology Research and Treatment 2025; 48(10): 624 doi: 10.1159/000546337
43
Yubin Hai, Tingting Lin, Guangyi Wang, Xiaodong Sun, Lan Wang, Yuying Hai, Saisai Chen, Xiaoju Shi. Case report: Combination therapy for hepatocellular carcinoma with inferior vena cava or right atrial tumor thrombus in the era of combined targeted and immunotherapeutic agents. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1470374
44
Masaud Shah, Sung Ung Moon, Ji-Hye Choi, Min Jae Kim, Hyun Goo Woo. Peptide‑based therapeutics targeting the SLC39A14‑PIWIL2 fusion in hepatocellular carcinoma. Genomics & Informatics 2025; 23(1) doi: 10.1186/s44342-025-00060-5
45
Jae Yeon Lee, Min Jung Geum, Jong Hee Ko, Eun Sun Son, Yun Mi Yu. Comparative Effectiveness and Safety of Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma Based on Viral Etiology. Journal of Korean Society of Health-System Pharmacists 2024; 41(4): 354 doi: 10.32429/jkshp.2024.41.4.002
46
LINGLI ZHANG, YAN LI, JINGXIN MAO. Research progress on natural products against hepatocellular carcinoma. BIOCELL 2024; 48(6): 905 doi: 10.32604/biocell.2024.050396
47
Stanislav Nikolaevich Kotlyarov. Liver immunology: Biological role and clinical significance. World Journal of Hepatology 2025; 17(7): 107541 doi: 10.4254/wjh.v17.i7.107541
48
Habiba M. Ismail, Abdelrahman A. Attia, Amr Abdelaal, Rana A. Youness. MIAT, HEIH, and HOTAIR: A novel LncRNA signature in non-metastatic hepatocellular carcinoma patients. Current Molecular Pharmacology 2025; 18(1): 83 doi: 10.1016/j.cmp.2025.11.002
49
Dan Liu, Runtian Li, Mingzhu Li, Ying Liang, Zhao Wang, Yang Sun, Pengling Ge. Colon-Targeted astragalus polysaccharide nanoparticles prevent NAFLD-Driven hepatocarcinogenesis via microbiota remodeling and NF-κB Inhibition. Journal of Experimental & Clinical Cancer Research 2025; 44(1) doi: 10.1186/s13046-025-03608-z
50
Taotao Yan, Jiahai Shi. Angiogenesis and EMT regulators in the tumor microenvironment in lung cancer and immunotherapy. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1509195
51
Federico Rossari, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Francesca Bergamo, Elisabeth Amadeo, Francesco Vitiello, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Massimo Iavarone, Giuseppe Cabibbo, Margarida Montes, Francesco Giuseppe Foschi, Caterina Vivaldi, Caterina Soldà, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Hiraoka, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Foti, Silvia Camera, Bernardo Stefanini, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardini, Margherita Rimini. Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study. Liver Cancer 2024; 13(5): 522 doi: 10.1159/000537915
52
Chun-Bo Li, Yu-Ting Ning, Nai-Ying Shen, Ben Wang, Han Xiao, Gang Luo. Systemic treatment of liver cancer: Current status and future perspectives. World Journal of Hepatology 2025; 17(7): 107520 doi: 10.4254/wjh.v17.i7.107520
53
Wen-qing Liang, Chongze Yang, Lan-hui Qin, Meng-na Lan, Pro. Jin-yuan Liao. Radiomics-based Machine Learning for Predicting Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Academic Radiology 2025; 32(11): 6478 doi: 10.1016/j.acra.2025.07.008
54
Durmuş Ayan, Şerife Buket Bozkurt Polat, Ergül Bayram, Esma Özmen, Fatma Esin Aydın, Serpil Ersan. A Comparative Analysis of the Roles of von Willebrand Factor and ADAMTS13 in Hepatocellular Carcinoma: A Bioinformatics and Microarray-Based Study. Current Issues in Molecular Biology 2025; 47(4): 270 doi: 10.3390/cimb47040270
55
Haiyan Fu, Qiuhong Wang, Haiwen Li, Hongjuan Li, Jie Li, Yu Liu, Futao Dang, Lifeng Wang, Xuan Zhang, Yongrui Yang, Yingrong Du. LINC02987 suppression hepatocellular carcinoma progression by modulating autophagy via the miR-338-3p/ATG12 axis. Experimental Cell Research 2025; 444(2): 114398 doi: 10.1016/j.yexcr.2024.114398
56
Nicolò Brandi, Matteo Renzulli. The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(10): 8598 doi: 10.3390/ijms24108598
57
Yenisetti Rajendra Prasad, J. Anakha, Abhay H. Pande. Treating liver cancer through arginine depletion. Drug Discovery Today 2024; 29(4): 103940 doi: 10.1016/j.drudis.2024.103940
58
Zhaomin Deng, Lu Pu, Yongxin Ma, Hao Jiang, Tao Liu. Identification and functional analysis of five hub lncRNAs associated with oncogenesis of Hepatocellular Carcinoma. PLOS One 2025; 20(4): e0321875 doi: 10.1371/journal.pone.0321875
59
Waleed Kian, Areen A. Remilah, Celine Shatat, Maria Spector, Laila C. Roisman, Larisa Ryvo. Case report: The efficacy of adding high doses of intravenous vitamin C to the combination therapy of atezolizumab and bevacizumab in unresectable HCC. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1461127
60
Xiaoqin Wu. Conversion Therapy and Liver Regeneration in Liver Cancer. Journal of Biosciences and Medicines 2025; 13(12): 374 doi: 10.4236/jbm.2025.1312028
61
Jin Sun. Comprehensive analysis identifies long non-coding RNA RNASEH1-AS1 as a potential prognostic biomarker and oncogenic target in hepatocellular carcinoma. American Journal of Cancer Research 2024; 14(3): 996 doi: 10.62347/JPHF4071
62
Yue Yin, Weibo Feng, Jie Chen, Xilang Chen, Guodong Wang, Shuai Wang, Xiao Xu, Yongzhan Nie, Daiming Fan, Kaichun Wu, Limin Xia. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside. Experimental Hematology & Oncology 2024; 13(1) doi: 10.1186/s40164-024-00539-x
63
Kashif Asghar, Shaarif Bashir, Muhammad Hassan, Asim Farooq, Muhammad Abu Bakar, Sundus Bilal, Maryam Hameed, Shafqat Mehmood, Asif Loya. Expression of PD-L1 clones (22C3 and 28-8) in hepatocellular carcinoma: a tertiary cancer care hospital experience. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00310-1
64
Margherita Rimini, Lorenzo Fornaro, Sara Lonardi, Monica Niger, Daniele Lavacchi, Tiziana Pressiani, Jessica Lucchetti, Guido Giordano, Andrea Pretta, Emiliano Tamburini, Chiara Pirrone, Ilario Giovanni Rapposelli, Anna Diana, Erika Martinelli, Ingrid Garajová, Francesca Simionato, Marta Schirripa, Vincenzo Formica, Caterina Vivaldi, Enrico Caliman, Mario Domenico Rizzato, Valentina Zanuso, Federico Nichetti, Lorenzo Angotti, Matteo Landriscina, Mario Scartozzi, Matteo Ramundo, Alessandro Pastorino, Bruno Daniele, Noemi Cornara, Mara Persano, Eleonora Gusmaroli, Riccardo Cerantola, Francesca Salani, Francesca Ratti, Luca Aldrighetti, Stefano Cascinu, Lorenza Rimassa, Lorenzo Antonuzzo, Andrea Casadei‐Gardini. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data. Liver International 2023; 43(8): 1803 doi: 10.1111/liv.15641
65
Thomas M. Ruli, Ethan D. Pollack, Atul Lodh, Charles D. Evers, Christopher A. Price, Mohamed Shoreibah. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review. Cancers 2024; 16(11): 2042 doi: 10.3390/cancers16112042
66
Ersin Karatayli, Shifana C. Sadiq, Jörn M. Schattenberg, Stephan Grabbe, Bernhard Biersack, Leonard Kaps. Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle Formulations. Cancers 2025; 17(3): 484 doi: 10.3390/cancers17030484
67
Elham Rismani, Nikoo Hossein-Khannazer, Moustapha Hassan, Elahe Shams, Mustapha Najimi, Massoud Vosough. Targeting glypican 3 by immunotoxins: the promise of immunotherapy in hepatocellular carcinoma. Expert Opinion on Therapeutic Targets 2025; 29(1-2): 59 doi: 10.1080/14728222.2025.2471581
68
JunJun Jia, Xuelian Zhou, Qingfei Chu. Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer. Molecular and Cellular Biochemistry 2025; 480(1): 1 doi: 10.1007/s11010-024-04983-5
69
Parissa Tabrizian, Adriana Pero, Myron Schwartz. Hepatic Resection for Hepatocellular Carcinoma. Clinics in Liver Disease 2025; 29(1): 59 doi: 10.1016/j.cld.2024.08.008
70
Reza Elahi, Yassine Alami Idrissi, Anwaar Saeed. CAR-T cell therapy in hepatocellular carcinoma: from mechanistic insights to clinical translation. Cancer Treatment Reviews 2025; 141: 103046 doi: 10.1016/j.ctrv.2025.103046
71
Vanessa Chan, Hsin‐Mei Lee, Haruka Takata, Sheng‐Liang Cheng, Yu‐Ting Yen, Lisa Pfeifer, Luke Rushton, Po‐Han Chao, Feng Zhao, Chun Yat Ong, Nojoud Al‐Fayez, Tatsuhiro Ishida, Yunching Chen, Shyh‐Dar Li. Imiquimod‐Loaded Phospholipid‐Free Small Unilamellar Vesicles Activate the Tumor Immune Microenvironment to Treat Liver Cancer and Liver Metastases. Advanced Healthcare Materials 2025; 14(22) doi: 10.1002/adhm.202501691
72
Donato Longo, Chiara Favini, Martina Managlia, Ciro Bellotta, Maria Rina Starace, Simona Casaioli, Stefania Roncarati, Annarosa Saviozzi, Juri Ducci. TRANSPLANT ONCOLOGY FOR DONATION AND TRANSPLANT NURSES: A CALL TO ACTION. European Journal of Transplantation 2025; 3(1): 54 doi: 10.57603/EJT-1560
73
Jian-Hong Zhong. Adjuvant therapy for hepatocellular carcinoma: Dilemmas at the start of a new era. World Journal of Gastroenterology 2024; 30(8): 806-810 doi: 10.3748/wjg.v30.i8.806
74
Cheng Zeng, Shiyuan Hua, Jiayu Zhou, Tangye Zeng, Jianke Chen, Lijian Su, Angfeng Jiang, Min Zhou, Zhe Tang. Oral Microalgae‐Based Biosystem to Enhance Irreversible Electroporation Immunotherapy in Hepatocellular Carcinoma. Advanced Science 2025; 12(15) doi: 10.1002/advs.202409381
75
Mohamed Kamal Shaker, Ashraf Omar, Hesham Elghazaly, Ghassan Aboualfa. Approach to Hepatocellular Carcinoma (HCC) Management in Low/Middle-Income Countries. 2025; : 217 doi: 10.1007/978-981-96-3894-9_8
76
Stavros P. Papadakos, Elena Chatzikalil, Georgios Vakadaris, Lampros Reppas, Konstantinos Arvanitakis, Theocharis Koufakis, Spyros I. Siakavellas, Spilios Manolakopoulos, Georgios Germanidis, Stamatios Theocharis. Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma. Cancers 2024; 16(14): 2609 doi: 10.3390/cancers16142609
77
Ludovico Abenavoli, Michele Montori, Gianluca Svegliati Baroni, Maria Eva Argenziano, Francesca Giorgi, Giuseppe Guido Maria Scarlata, Francesca Ponziani, Emidio Scarpellini. Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors. Medicina 2023; 59(8): 1427 doi: 10.3390/medicina59081427
78
Wen Wen, Yingshuang Chen, Fangqing Gao, Liling Tong. Knowledge, attitudes and practices relating to nutritional support and immune-related adverse events among patients undergoing immunotherapy for liver cancer: cross-sectional study. BMJ Open 2025; 15(5): e086854 doi: 10.1136/bmjopen-2024-086854
79
Céleste Plantureux, Juliette Paillet, Gwennhael Autret, Maria Pérez-Lanzón, Guido Kroemer, Maria Chiara Maiuri, Jonathan Pol. Liver Carcinogenesis. Methods in Molecular Biology 2024; 2769: 99 doi: 10.1007/978-1-0716-3694-7_8
80
Santosh K. Mandal, Poonam Yadav, Rahul A. Sheth. The Neuroimmune Axis and Its Therapeutic Potential for Primary Liver Cancer. International Journal of Molecular Sciences 2024; 25(11): 6237 doi: 10.3390/ijms25116237
81
Shaimaa Gad, Ruisong Ye, Wei Qiu. In vivo CRISPR Activation Screening, a Powerful Tool to Discover Oncogenic Driver Genes in Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology 2025; 19(5): 101459 doi: 10.1016/j.jcmgh.2024.101459
82
Keisuke Sawada, Hak Chung, Samir Softic, Maria E. Moreno-Fernandez, Senad Divanovic. The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metabolism 2023; 35(11): 1852 doi: 10.1016/j.cmet.2023.10.009
83
Alexsis Garcia, Stephen O. Mathew. Racial/Ethnic Disparities and Immunotherapeutic Advances in the Treatment of Hepatocellular Carcinoma. Cancers 2024; 16(13): 2446 doi: 10.3390/cancers16132446
84
KURT SARTORIUS, BENN SARTORIUS, CHERIE WINKLER, ANIL CHUTURGOON, ANNA KRAMVIS, PING AN, WEIGANG ZHANG, YUNJIE LU. The roles and mechanisms of miRNA in HBV-HCC carcinogenesis: Why no therapeutic agents after 30 years?. BIOCELL 2024; 48(11): 1543 doi: 10.32604/biocell.2024.055505
85
Qiuyu Zhuang, Zhiguo Dai, Xuechun Xu, Shaoyi Bai, Yindan Zhang, Youshi Zheng, Xiaohua Xing, En Hu, Yingchao Wang, Wuhua Guo, Bixing Zhao, Yongyi Zeng, Xiaolong Liu. RNA Methyltransferase FTSJ3 Regulates the Type I Interferon Pathway to Promote Hepatocellular Carcinoma Immune Evasion. Cancer Research 2024; 84(3): 405 doi: 10.1158/0008-5472.CAN-23-2049
86
Aydin Eresen, Zigeng Zhang, Guangbo Yu, Qiaoming Hou, Zhilin Chen, Zeyang Yu, Vahid Yaghmai, Zhuoli Zhang. Sorafenib plus memory-like natural killer cell immunochemotherapy boosts treatment response in liver cancer. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12718-4
87
Yuan Li, Wenna Liu, Xushen Fan, Xinyi Wu, Mingbo Cao, Xiuling Li, Amin Wurita, Suofeng Sun. FAIM modulates HCC progression via enhancing HMGA1 interaction with CDK7 and promoting its phosphorylation level. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-07148-0
88
Parissa Tabrizian, Rebecca Marino, Pierce K.H. Chow. Liver resection and transplantation in the era of checkpoint inhibitors. JHEP Reports 2024; 6(11): 101181 doi: 10.1016/j.jhepr.2024.101181
89
Ke Ma, Ye Shen, Jiahui Hu, JueBao Li, Xingru Zhang. Curcumin as a therapeutic agent in liver cancer: a systematic review of preclinical models and mechanisms. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02922-8
90
Xia-Qing Zhou, Ya-Ping Li, Shuang-Suo Dang. Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy. World Journal of Hepatology 2024; 16(2): 164-176 doi: 10.4254/wjh.v16.i2.164
91
Lara Caglayan, Oliver Blanck, Judit Boda-Heggemann, Thomas Brunner, Cas Stefaan Dejonckheere, Dan G. Duda, Elke Firat, Maria Hawkins, Julian Philipp Layer, Leitzen Christina, Alejandra Mendez-Romero, Gabriele Niedermann, Younèss Nour, Falk Röder, Gustavo Renato Sarria, Davide Scafa, Marta Scorsetti, Wiegreffe Shari, Anca-L. Grosu, Eleni Gkika. Evaluating the efficacy and immunological impact of combined ICIs and SBRT in HCC: A narrative literature review. Clinical and Translational Radiation Oncology 2026; : 101106 doi: 10.1016/j.ctro.2026.101106
92
Mahsa Ghasemian-Irani, Shabnam Babaei, Tohid Kazemi. Exosomes in hepatocellular carcinoma: involvement in reprogramming the tumor microenvironment for immune evasion, metastasis, angiogenesis, and drug resistance. Cell Cycle 2025; 24(21-24): 529 doi: 10.1080/15384101.2025.2583289
93
Liman Qiu, Hongbing Ji, Kai Wang, Wenhan Liu, Qizhen Huang, Xinting Pan, Honghao Ye, Zhenli Li, Geng Chen, Xiaohua Xing, Xiuqing Dong, Ruijing Tang, Haipo Xu, Jingfeng Liu, Zhixiong Cai, Xiaolong Liu. TLR3 activation enhances abscopal effect of radiotherapy in HCC by promoting tumor ferroptosis. EMBO Molecular Medicine 2024; 16(5): 1193 doi: 10.1038/s44321-024-00068-4
94
Ram Prasad Chaulagain, Aadil Mushtaq Padder , Harisharan Shrestha , Radheshyam Gupta, Rameshor Bhandari , Yelona Shrestha , Abdulkareem Qasem Moqbel, Smriti Gautam, Nand Lal, Shizhu Jin. Deciphering the Matrisome: Extracellular Matrix Remodeling in Liver Cirrhosis and Hepatocellular Carcinoma. Cureus 2025;  doi: 10.7759/cureus.82171
95
So Jung Lee, Myungsoo Kim. Magnetic resonance imaging-guided radiotherapy for portal vein tumor thrombus in hepatocellular carcinoma: outcomes and prognostic factors. Radiation Oncology 2025; 20(1) doi: 10.1186/s13014-025-02717-5
96
Changyou Jing, Tong Zhu, Yonghong Zhang, Jianjun Li. The combination treatment of oncolytic adenovirus H101 with transcatheter arterial embolization sequential thermal ablation for hepatocellular carcinoma: a retrospective study. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1623877
97
Yongxin Yu, Yulang Jiang, Yipeng Yang, Christian Glandorff, Wenzheng Fang, Mingyu Sun. Synergistic Strategies in Systemic Therapy for Advanced Hepatocellular Carcinoma. Global Challenges 2026; 10(1) doi: 10.1002/gch2.202500247
98
Mirco Castoldi, Sanchari Roy, Carolin Angendohr, Rossella Pellegrino, Mihael Vucur, Michael T. Singer, Veronika Buettner, Matthias A. Dille, Stephanie D. Wolf, Lara R. Heij, Ahmed Ghallab, Wiebke Albrecht, Jan G. Hengstler, Georg Flügen, Wolfram T. Knoefel, Johannes G. Bode, Lars Zender, Ulf P. Neumann, Mathias Heikenwälder, Thomas Longerich, Christoph Roderburg, Tom Luedde. Regulation of KIF23 by miR-107 controls replicative tumor cell fitness in mouse and human hepatocellular carcinoma. Journal of Hepatology 2025; 82(3): 499 doi: 10.1016/j.jhep.2024.08.025
99
Mengmeng Dong, Yumeng Liu, Yuting Xiao, Qingqing Wu, Mingjing Guan, Zunqiang Xiao, Junwei Liu, Lidong Cao, Yi Lu. Tumor-Targeted PLGA Nanospheres Enhance Therapeutic Effect of Lenvatinib in Hepatocellular Carcinoma via Photothermal and Photodynamic Therapy. ACS Applied Materials & Interfaces 2025;  doi: 10.1021/acsami.5c09045
100
Xuanshuang Du, Wenwen Zhang, Sujuan Sun, Chenghao Liu, Yuanying He, Fengling Luo, Hongyan Wu, Min Liu. G0S2 Promotes PD-L1 Expression in Monocytes and Influences the Efficacy of PD-1 Inhibitors in Hepatocellular Carcinoma. Genes 2025; 16(4): 448 doi: 10.3390/genes16040448
101
Autophagy Regulators p62/SQSTM1 and NBR1 as new Predictive Biomarkers of Immunotherapy Response in Hepatocellular Carcinoma. UMYU Scientifica 2025; 4(3): 264 doi: 10.56919/usci.2543.027
102
Zhe Li, Lixia Chen, Ruifeng Zeng, Yi Shen, Jinshuai Lan, Tong Zhang, Yue Ding. Simultaneous induction of immunogenic cell death and PD-L1 downregulation by bufalin-based nanovaccines for potentiate HCC immunotherapy. Materials Today Bio 2025; 35: 102294 doi: 10.1016/j.mtbio.2025.102294
103
Hengyu Tian, Chidan Wan. Comparative efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors versus tyrosine kinase inhibitors and immune checkpoint inhibitors alone in advanced hepatocellular carcinoma: a systematic review and meta-analysis. World Journal of Surgical Oncology 2025; 23(1) doi: 10.1186/s12957-025-03788-0
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345